Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tejnaksh Healthcare Ltd has informed BSE that its Board of Directors will meet on Saturday, 07 February 2026 at its registered office in Mumbai. The key agenda item is to consider and approve the Un-Audited Standalone and Consolidated Financial Results for the quarter ended 31 December 2025 (Q3 FY26). Any other business may also be taken up with the Chair's permission. The company has also reminded the stock exchange that the trading window for dealing in shares remains closed from 28 December 2025 until 48 hours after the results are declared.
This is a routine pre-results intimation and does not contain actual financial numbers. Shareholders should watch for the Q3 FY26 results on 7 February, as the unaudited numbers could move the stock once declared.